Press releases
Advitech announces the hiring of Carl Cappabianca as Director, Sales and Marketing.
12 April 2010
QUEBEC CITY, QUEBEC - April 12, 2010 - Advitech Inc. ("Advitech") announces today the hiring of Carl Cappabianca as Director, Sales and Marketing. Carl will concentrate on sales, marketing and business expansion activities with particular focus on the continued strong growth of the Oleosome technology of Advitech's subsidiary, Botaneco Specialty Ingredients Inc. ("Botaneco"). Carl was most recently at Consumer Product Testing Company where he headed sales, marketing and new business development leading these efforts in their six testing disciplines. Previously, Carl was with Jeen International and Lonza where he served primarily as global leader of their Personal Care business units. He has also held numerous senior management sales, marketing, operations and business development roles in Personal Care, Industrial and related segments with Honeywell and Ashland Chemical.
"I'm pleased to welcome Carl to the Botaneco team. His energy, expertise, and strong history of producing both short- and long-term results will be a tremendous asset to our team" said Mike Stangel, President and CEO. Mr. Cappabianca earned a Bachelor of Science degree in Biology and Chemistry from Fairfield University in Connecticut and an MBA in Marketing with a Finance minor from Fairleigh Dickinson University in New Jersey.
About Advitech
Advitech, which includes its subsidiary Botaneco Specialty Ingredients Inc. since November 20, 2009, is a health sciences and technology company developing, manufacturing and marketing proprietary natural ingredients and formulations for oral and topical applications that have been clinically proven to be safe and effective for improving skin health and well being. The Corporation's products are based on three technological platforms which are: i) a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, ii) XP-828L for immune mediated inflammatory disorders, and iii) IM for anti-aging and wound healing. Advitech produces HydresiaTM, a natural plant derived specialty ingredient which offers immediate moisturization advantages, formulating cost savings and excellent product aesthetics in a variety of product applications, Dermylex® for the treatment of mild-to-moderate psoriasis, and NudremylTM which acts on skin reconstruction, cellular regeneration and skin structure. More information is available and can be accessed at
www.advitech.com and www.botaneco.ca.
This press release contains forward-looking statements, which reflect the Corporation's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Michael Stangel, President and CEO
Advitech Inc.
418-948-4084
215-604-0631
info@advitech.com